|
How many volunteers were present at the Congress? : |
2500 |
|
Delegates from which countries presented in the congress? : |
Germany, Poland, France, Russia, Turkey, Italy,... |
|
Were the delegates of any other organizations present in the congress? : |
No |
|
If yes, please write the names of the organizations in the box : |
|
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
One of the major point of my poster presentation was to find a SCID newborn using TREC/KREC screening method by quantitative multiplex Real Time PCR technique. |
|
If you met staff members, please list their full names & positions. : |
I did not have any meeting with the staff and it was just for the registration process and CME credits. |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
The results of the multiplex quantitative real time PCR showed undetectable TREC but a high level of KREC copy numbers. We subsequently found a novel substitution in the IL2RG encoding gene (X-SCID): c.675 C>A, leading to p.225 Ser>Arg. Based on the functional analysis using PolyPhen, the mutation is predicted to be damaging. The patient was thus diagnosed as a T- B+ NK- X-linked SCID. |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
That was excellent. No problem has happened to me. |
|
Please give a briefing of your own observations and outcomes of the congress: : |
The most important focus of lectures was on using immune cells especially T cells and dendritic cells for cancer immunotherapy. Also, it was so surprising that a lot of studies designed to do from bench to beside. It means that in such a multicenter projects, scientists try to perform the experimental research study and subsequently use the results for clinical trial approaches. Also, I found that the same work that I've done for screening the immunodeficiency disorders especially SCID, has been designed to do in the other European countries. |